Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
breast cancer
MedTech
FDA clears Clairity's 5-year breast cancer risk prediction tool
The FDA’s de novo clearance paves the way for Clairity to launch the risk prediction platform with leading health systems through 2025.
Heather Landi
Jun 5, 2025 1:00pm
Guardant360-guided breast cancer therapy swaps boost survival
Jun 3, 2025 10:00am
AstraZeneca's breast cancer pill boosts PFS by 56% in phase 3
Jun 2, 2025 7:10am
Arvinas lays off 33% of staff, axes Pfizer-partnered trials
May 1, 2025 8:50am
Study illustrates pros, cons of AI readings in 3D mammography
Apr 25, 2025 12:00pm
RadNet to absorb mammography AI developer iCad in $103M deal
Apr 16, 2025 2:05pm
